GATA6 mutations: Characterization of two novel patients and a comprehensive overview of the GATA6 genotypic and phenotypic spectrum.
Adult
Child
GATA6 Transcription Factor
/ genetics
Gallbladder
/ physiopathology
Genetic Predisposition to Disease
Genotype
Heart
/ diagnostic imaging
Heart Defects, Congenital
/ diagnostic imaging
Hernias, Diaphragmatic, Congenital
/ diagnostic imaging
Heterozygote
Humans
Loss of Function Mutation
/ genetics
Male
Mutation
Pancreas
/ diagnostic imaging
Phenotype
Truncus Arteriosus, Persistent
/ diagnostic imaging
Exome Sequencing
GATA6
congenital heart disease
heart
mutation
pancreas
phenotypic spectrum
Journal
American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
14
01
2019
revised:
29
04
2019
accepted:
11
06
2019
pubmed:
14
7
2019
medline:
4
8
2020
entrez:
14
7
2019
Statut:
ppublish
Résumé
The first human mutations in GATA6 were described in a cohort of patients with persistent truncus arteriosus, and the phenotypic spectrum has expanded since then. This study underscores the broad phenotypic spectrum by presenting two patients with de novo GATA6 mutations, both exhibiting complex cardiac defects, pancreatic, and other abnormalities. Furthermore, we provided a detailed overview of all published human genetic variation in/near GATA6 published to date and the associated phenotypes (n = 78). We conclude that the most common phenotypes associated with a mutation in GATA6 were structural cardiac and pancreatic abnormalities, with a penetrance of 87 and 60%, respectively. Other common malformations were gallbladder agenesis, congenital diaphragmatic hernia, and neurocognitive abnormalities, mostly developmental delay. Fifty-eight percent of the mutations were de novo, and these patients more often had an anomaly of intracardiac connections, an anomaly of the great arteries, and hypothyroidism, compared with those with inherited mutations. Functional studies mostly support loss-of-function as the pathophysiological mechanism. In conclusion, GATA6 mutations give a wide range of phenotypic defects, most frequently malformations of the heart and pancreas. This highlights the importance of detailed clinical evaluation of identified carriers to evaluate their full phenotypic spectrum.
Identifiants
pubmed: 31301121
doi: 10.1002/ajmg.a.61294
pmc: PMC6772993
doi:
Substances chimiques
GATA6 Transcription Factor
0
GATA6 protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1836-1845Subventions
Organisme : Hartstichting
ID : 2014T053
Pays : International
Organisme : Hartstichting
ID : CVON 2014-18
Pays : International
Organisme : Children's Heart Foundation
Pays : International
Informations de copyright
© 2019 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals, Inc.
Références
Mol Cell Endocrinol. 2004 Oct 29;226(1-2):51-7
pubmed: 15489005
Dev Biol. 2003 Feb 1;254(1):131-48
pubmed: 12606287
Circ J. 2012;76(7):1703-11
pubmed: 22498567
Circ Res. 2013 Feb 15;112(4):707-20
pubmed: 23410880
DNA Cell Biol. 2012 Nov;31(11):1610-7
pubmed: 23020118
Curr Top Dev Biol. 2012;100:253-77
pubmed: 22449847
J Am Coll Cardiol. 2011 Nov 15;58(21):2241-7
pubmed: 22078432
Nature. 2013 Jun 13;498(7453):220-3
pubmed: 23665959
Nat Genet. 2011 Dec 11;44(1):20-22
pubmed: 22158542
Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H1952-64
pubmed: 21908788
Dev Biol. 2006 Oct 15;298(2):415-29
pubmed: 16887115
Circ Res. 2017 Mar 17;120(6):923-940
pubmed: 28302740
Nat Genet. 2016 Dec;48(12):1557-1563
pubmed: 27798624
J Clin Endocrinol Metab. 2018 Jan 1;103(1):35-45
pubmed: 28938416
Genes Dev. 1998 Nov 15;12(22):3579-90
pubmed: 9832509
Diabetes. 2013 Mar;62(3):993-7
pubmed: 23223019
BMC Med Genet. 2016 Apr 21;17:32
pubmed: 27098067
Circulation. 2009 Jul 28;120(4):295-301
pubmed: 19597048
Mol Med Rep. 2014 Aug;10(2):743-8
pubmed: 24841381
Arch Intern Med. 1995 Mar 13;155(5):469-73
pubmed: 7864703
Nat Genet. 1998 Sep;20(1):87-91
pubmed: 9731539
Nat Genet. 2016 Sep;48(9):1060-5
pubmed: 27479907
Nat Genet. 2017 Nov;49(11):1593-1601
pubmed: 28991257
PLoS One. 2016 Aug 04;11(8):e0160519
pubmed: 27490490
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Nat Genet. 2018 Sep;50(9):1234-1239
pubmed: 30061737
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13933-8
pubmed: 19666519
Gene. 2018 Jan 30;641:341-348
pubmed: 29101065
J Thorac Cardiovasc Surg. 1998 May;115(5):1063-73
pubmed: 9605076
Expert Rev Mol Med. 2006 Sep 15;8(22):1-20
pubmed: 16987437
J Biol Chem. 2000 Dec 15;275(50):38949-52
pubmed: 11042222
Genome Res. 2005 Jul;15(7):901-13
pubmed: 15965027
Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11189-94
pubmed: 16847256
J Am Coll Cardiol. 2013 May 7;61(18):1935-44
pubmed: 23558044
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Cardiol Young. 2017 Dec;27(10):1872-1938
pubmed: 29286277
Am J Med Genet A. 2019 Sep;179(9):1836-1845
pubmed: 31301121
J Med Genet. 2014 Mar;51(3):197-202
pubmed: 24385578
J Clin Invest. 2006 Apr;116(4):929-39
pubmed: 16557299
Pediatr Res. 2010 Oct;68(4):281-5
pubmed: 20581743
J Hum Genet. 2010 Oct;55(10):662-7
pubmed: 20631719
Horm Res Paediatr. 2013;79(4):250-6
pubmed: 23635550
Int J Mol Med. 2012 Jun;29(6):1065-71
pubmed: 22407241
Science. 2015 Dec 4;350(6265):1262-6
pubmed: 26785492